Skip to main content

Table 1 Quality assessment of trials of elective induction of labour versus expectant management for post-term pregnancies

From: Elective induction for pregnancies at or beyond 41 weeks of gestation and its impact on stillbirths: a systematic review with meta-analysis

 

Quality Assessment

Summary of Findings

    

Directness

No of events

 

No of studies (ref)

Design

Limitations

Consistency

Generalizability to population of interest

Generalizability to intervention of interest

Intervention

Control

Relative Risk (95% CI)

Mortality (Stillbirth): 'MODERATE' outcome specific quality

14

All RCTs; only 4 out of 14 RCTs report estimable differences in stillbirth between the two groups

Small sample size in 12 studies; result statistically insignificant; wide CI: low precision

All studies are consistent in showing a tendency towards reduction of stillbirth as an outcome i.e. the direction of effect is towards benefit

5 in developing countries; rest in developed

Yes

0

4

RR (fixed): 0.29 (0.06 - 1.38)

Mortality (Perinatal mortality): 'MODERATE' outcome specific quality

14

All RCTs; only 8 out of 14 RCTs report estimable differences in perinatal mortality between the two groups

Small sample size in 12 studies

All studies are consistent in showing a tendency towards reduction in perinatal mortality as an outcome i.e. the direction of effect is towards benefit

5 in developing countries; rest in developed

Yes

1

10

RR (fixed): 0.31 (0.11 - 0.88)

Serious morbidity (Meconium aspiration syndrome):'MODERATE' outcome specific quality

7

All RCTs

Small sample sizes in all studies

Consistent with 5/7 studies showing direction of benefit

3 out of 7 in developing countries

Yes

14

33

RR (fixed): 0.43 (0.23 - 0.79)

Serious morbidity (Birth asphyxia): 'MODERATE' outcome specific quality

2

RCTs

Small sample sizes

Both the studies show a direction towards increased risk

1/2 in developing countries

Yes

6

3

RR (fixed): 1.86 (0.51 - 6.76)

Mild morbidity (Macrosomia): 'MODERATE' outcome specific quality

7

All RCTs

Small sample sizes except in one study

6/7 studies showing direction of benefit i.e. consistent

2/7 in developing countries

Yes

279

383

RR (random): 0.72 (0.54 - 0.98)